{"id":"NCT01993875","sponsor":"Mallinckrodt","briefTitle":"Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation","officialTitle":"A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Pharmacodynamics, Pharmacokinetics, and Tolerability of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2013-11-25","resultsPosted":"2019-12-13","lastUpdate":"2019-12-13"},"enrollment":164,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Idiopathic Constipation"],"interventions":[{"type":"DRUG","name":"Lubiprostone","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Lubiprostone","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the pharmacodynamics and tolerability of a liquid formulation of lubiprostone, as compared to matching placebo, when administered orally to subjects with chronic idiopathic constipation. Additionally, liquid formulation pharmacokinetics, including a comparison of fed and fasted pharmacokinetics, of the liquid formulation will be performed in a subset of subjects.","primaryOutcome":{"measure":"Number of Spontaneous Bowel Movements (SBMs) Within 1 Week","timeFrame":"within 1 week","effectByArm":[{"arm":"Lubiprostone","deltaMin":4.6,"sd":3.33},{"arm":"Placebo","deltaMin":4,"sd":3.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1290"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":11,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":82},"commonTop":["Headache","Flatulence","Nausea","Presyncope","Abdominal distension"]}}